Literature DB >> 21478480

Effect of medial calcification on vascular function in uremia.

Roy L Sutliff1, Erik R Walp, Alexander M El-Ali, Stacey Elkhatib, Koba A Lomashvili, W Charles O'Neill.   

Abstract

The contribution of medial calcification to vascular dysfunction in renal failure is unknown. Vascular function was measured ex vivo in control, noncalcified uremic, and calcified uremic aortas from rats with adenine-induced renal failure. Plasma urea was 16 ± 4, 93 ± 14, and 110 ± 25 mg/dl, and aortic calcium content was 27 ± 4, 29 ± 2, and 4,946 ± 1,616 nmol/mg dry wt, respectively, in the three groups. Maximal contraction by phenylephrine (PE) or KCl was reduced 53 and 63% in uremic aortas, and sensitivity to KCl but not PE was increased. Maximal relaxation to acetylcholine was impaired in uremic aortas (30 vs. 65%), and sensitivity to nitroprusside was also reduced, indicating some impairment of endothelium-independent relaxation as well. None of these parameters differed between calcified and noncalcified uremic aortas. However, aortic compliance was reduced in calcified aortas, ranging from 17 to 61% depending on the severity of calcification. We conclude that uremic vascular calcification, even when not severe, significantly reduces arterial compliance. Vascular smooth muscle and endothelial function are altered in renal failure but are not affected by medial calcification, even when severe.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478480      PMCID: PMC3129884          DOI: 10.1152/ajprenal.00533.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

1.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility.

Authors:  G Zhao; R L Sutliff; C S Weber; J Wang; J Lorenz; R J Paul; J A Fagin
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

3.  Regional pulse-wave velocity in the arterial tree.

Authors:  D A McDonald
Journal:  J Appl Physiol       Date:  1968-01       Impact factor: 3.531

4.  Diminished vascular response to noradrenaline in experimental chronic uremia.

Authors:  W Rascher; A Schömig; V A Kreye; E Ritz
Journal:  Kidney Int       Date:  1982-01       Impact factor: 10.612

5.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

6.  Impaired endothelial function in isolated human uremic resistance arteries.

Authors:  S T Morris; J J McMurray; A Spiers; A G Jardine
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

7.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

Review 8.  Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.

Authors:  Andrew P Somlyo; Avril V Somlyo
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

9.  Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.

Authors:  C Beretta-Piccoli; P Weidmann; H Schiffl; C Cottier; F C Reubi
Journal:  Kidney Int       Date:  1982-09       Impact factor: 10.612

10.  Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Authors:  Koba A Lomashvili; Marie-Claude Monier-Faugere; Xiaonan Wang; Hartmut H Malluche; W Charles O'Neill
Journal:  Kidney Int       Date:  2009-01-07       Impact factor: 10.612

View more
  13 in total

1.  Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder.

Authors:  J Ruth Wu-Wong; Yung-Wu Chen; Jonathan T Wong; Jerry L Wessale
Journal:  Br J Pharmacol       Date:  2016-06-12       Impact factor: 8.739

2.  Arterial compliance across the spectrum of ankle-brachial index: the Multiethnic Study of Atherosclerosis.

Authors:  Scott M Lilly; David R Jacobs; Richard Kronmal; David A Bluemke; Michael Criqui; Joao Lima; Matthew Allison; Daniel Duprez; Patrick Segers; Julio A Chirinos
Journal:  Atherosclerosis       Date:  2014-02-12       Impact factor: 5.162

3.  Diosgenin attenuates vascular calcification in chronic renal failure rats.

Authors:  Jeganathan Manivannan; T R Barathkumar; Jeganathan Sivasubramanian; Pandian Arunagiri; Boobalan Raja; Elumalai Balamurugan
Journal:  Mol Cell Biochem       Date:  2013-02-20       Impact factor: 3.396

Review 4.  Regulatory circuits controlling vascular cell calcification.

Authors:  Tamer Sallam; Henry Cheng; Linda L Demer; Yin Tintut
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

5.  The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo.

Authors:  Holly C Williams; Jing Ma; Daiana Weiss; Bernard Lassègue; Roy L Sutliff; Alejandra San Martín
Journal:  Lab Invest       Date:  2018-10-05       Impact factor: 5.662

6.  Diosgenin improves vascular function by increasing aortic eNOS expression, normalize dyslipidemia and ACE activity in chronic renal failure rats.

Authors:  Jeganathan Manivannan; Elumalai Balamurugan; Thangarasu Silambarasan; Boobalan Raja
Journal:  Mol Cell Biochem       Date:  2013-08-23       Impact factor: 3.396

7.  Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease.

Authors:  Omar Z Ameer; Rochelle Boyd; Mark Butlin; Alberto P Avolio; Jacqueline K Phillips
Journal:  Front Physiol       Date:  2015-05-19       Impact factor: 4.566

8.  Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression.

Authors:  Ramon L Serrano; Weifang Yu; Robert Terkeltaub
Journal:  Atherosclerosis       Date:  2014-01-21       Impact factor: 5.162

9.  Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.

Authors:  Campbell R Sheen; Pia Kuss; Sonoko Narisawa; Manisha C Yadav; Jessica Nigro; Wei Wang; T Nicole Chhea; Eduard A Sergienko; Kapil Kapoor; Michael R Jackson; Marc F Hoylaerts; Anthony B Pinkerton; W Charles O'Neill; José Luis Millán
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

Review 10.  Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology.

Authors:  Tim D Hewitson; Stephen G Holt; Edward R Smith
Journal:  Front Immunol       Date:  2015-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.